Ogorek Anthony Joseph’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3K Sell
44
-4
-8% -$351 ﹤0.01% 567
2026
Q1
$4K Sell
48
-4
-8% -$367 ﹤0.01% 525
2025
Q4
$4K Buy
52
+11
+27% +$1.04K ﹤0.01% 521
2025
Q3
$4K Hold
41
﹤0.01% 533
2025
Q2
$3K Sell
41
-118
-74% -$11.4K ﹤0.01% 549
2025
Q1
$17K Buy
+159
New +$17K 0.01% 301
2020
Q2
Sell
-177
Closed -$17K 224
2020
Q1
$17K Buy
177
+1
+0.6% +$131 0.01% 85
2019
Q4
$25K Sell
176
-134
-43% -$18.5K 0.01% 71
2019
Q3
$41K Buy
+310
New +$40K 0.02% 43
2018
Q3
Sell
-103
Closed -$11K 160
2018
Q2
$11K Hold
103
0.01% 82
2018
Q1
$10K Hold
103
0.01% 79
2017
Q4
$12K Hold
103
0.01% 69
2017
Q3
$11K Hold
103
0.01% 39
2017
Q2
$12K Hold
103
0.01% 40
2017
Q1
$12K Hold
103
0.01% 39
2016
Q4
$13K Hold
103
0.01% 47
2016
Q3
$13K Hold
103
0.01% 47
2016
Q2
$12K Hold
103
0.01% 53
2016
Q1
$11K Hold
103
0.01% 49
2015
Q4
$10K Hold
103
0.01% 55
2015
Q3
$9K Hold
103
0.01% 47
2015
Q2
$11K Hold
103
0.01% 50
2015
Q1
$12K Hold
103
0.01% 44
2014
Q4
$11K Buy
+103
New +$10.9K 0.01% 42

Other funds holding ZBH

Ogorek Anthony Joseph's ZBH Position: Q2 2026 in Review

Ogorek Anthony Joseph reduced its Zimmer Biomet (ZBH) stake by 8.3% in Q2 2026, selling an estimated $351 and leaving 44 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #567.

Ogorek Anthony Joseph first reported a position in ZBH in Q4 2014 and has held it in 24 quarters since. The position peaked at $41K in Q3 2019. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Ogorek Anthony Joseph held 44 shares of Zimmer Biomet worth $3K as of Q2 2026.
  • Ogorek Anthony Joseph sold 4 Zimmer Biomet shares in Q2 2026, an estimated $351.
  • Zimmer Biomet made up ﹤0.01% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #567 holding.
  • Ogorek Anthony Joseph first reported a position in Zimmer Biomet in Q4 2014 and has held it in 24 quarters since.
  • Ogorek Anthony Joseph's Zimmer Biomet position peaked at $41K in Q3 2019.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.